BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 62 filers reported holding BOLT BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 94 | -90.6% | 0.00% | – |
| Q2 2022 | $2,000 | -50.0% | 1,000 | -28.9% | 0.00% | – |
| Q1 2022 | $4,000 | -81.8% | 1,406 | -69.3% | 0.00% | – |
| Q4 2021 | $22,000 | -29.0% | 4,578 | +87.9% | 0.00% | – |
| Q3 2021 | $31,000 | +158.3% | 2,437 | +206.9% | 0.00% | – |
| Q2 2021 | $12,000 | -69.2% | 794 | -32.9% | 0.00% | – |
| Q1 2021 | $39,000 | – | 1,183 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $5,183,000 | 2.45% |
| Nan Fung Group Holdings Ltd | 1,166,952 | $3,197,000 | 1.52% |
| Vivo Capital, LLC | 3,871,291 | $10,607,000 | 0.73% |
| Samsara BioCapital, LLC | 1,049,153 | $2,875,000 | 0.72% |
| Novo Holdings A/S | 4,503,991 | $12,341,000 | 0.65% |
| Sofinnova Investments, Inc. | 2,754,437 | $7,547,000 | 0.57% |
| Hawkeye Capital Management, LLC | 415,039 | $1,137,000 | 0.45% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,230,250 | $6,111,000 | 0.19% |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $1,972,000 | 0.11% |
| Echo Street Capital Management LLC | 123,804 | $5,493,000 | 0.04% |